Table of Contents Author Guidelines Submit a Manuscript
International Journal of Vascular Medicine
Volume 2014, Article ID 589412, 7 pages
http://dx.doi.org/10.1155/2014/589412
Clinical Study

Prognostic Significance of Circulating and Endothelial Progenitor Cell Markers in Type 2 Diabetic Foot

1Metabolism Disease and Clinical Nutrition Unit, Santa Maria di Ca’ Foncello Hospital, Piazza Ospedale 1, 31100 Treviso, Italy
2Department of Pathology, Santa Maria di Ca’ Foncello Hospital, Treviso, Italy
3Hematology Unit, Santa Maria di Ca’ Foncello Hospital, Treviso, Italy
4Immunohematology and Transfusion Service, Santa Maria di Ca’ Foncello Hospital, Treviso, Italy

Received 22 June 2013; Accepted 10 November 2013; Published 3 February 2014

Academic Editor: Georgios Vourliotakis

Copyright © 2014 Maria Sambataro et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. International Working Group of Diabetic Foot, International Consensus Document Italian Version Ed Mediserve, 2007.
  2. E. Faglia, L. Dalla Paola, G. Clerici et al., “Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003,” European Journal of Vascular and Endovascular Surgery, vol. 29, no. 6, pp. 620–627, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Faglia, G. Clerici, J. Clerissi et al., “When is a technically successful peripheral angioplasty effective in preventing above-the-ankle amputation in diabetic patients with critical limb ischaemia?” Diabetic Medicine, vol. 24, no. 8, pp. 823–829, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Graziani and A. Piaggesi, “Indications and clinical outcomes for below knee endovascular therapy: review article,” Catheterization and Cardiovascular Interventions, vol. 75, no. 3, pp. 433–443, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Norgren, W. R. Hiatt, J. A. Dormandy, M. R. Nehler, K. A. Harris, and F. G. R. Fowkes, “Inter-society consensus for the management of peripheral arterial disease (TASC II),” European Journal of Vascular and Endovascular Surgery, vol. 33, no. 1, pp. S1–S75, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. G. P. Fadini, S. Sartore, C. Agostini, and A. Avogaro, “Significance of endothelial progenitor cells in subjects with diabetes,” Diabetes Care, vol. 30, no. 5, pp. 1305–1313, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Li, A. K. Ogasawara, R. Yang et al., “KDR (VEGF receptor 2) is the major mediator for the hypotensive effect of VEGF,” Hypertension, vol. 39, no. 6, pp. 1095–1100, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Kim, H.-J. Cho, S.-W. Kim et al., “CD31+ cells represent highly angiogenic and vasculogenic cells in bone marrow: novel role of nonendothelial CD31+ cells in neovascularization and their therapeutic effects on ischemic vascular disease,” Circulation Research, vol. 107, no. 5, pp. 602–614, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. G. P. Fadini, M. Rattazzi, T. Matsumoto, T. Asahara, and S. Khosla, “Emerging role of circulating calcifying cells in the bone-vascular axis,” Circulation, vol. 125, pp. 2772–2781, 2012. View at Google Scholar
  10. E. Faglia, F. Favales, A. Quarantiello et al., “Angiographic evaluation of peripheral arterial occlusive disease and its role as a prognostic determinant for major amputation in diabetic subjects with foot ulcers,” Diabetes Care, vol. 21, no. 4, pp. 625–630, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Ferraro, S. Lymperi, S. Méndez-Ferrer et al., “Diabetes impairs hematopoietic stem cell mobilization by altering niche function,” Science Translational Medicine, vol. 3, no. 104, Article ID 104ra101, 2011. View at Google Scholar · View at Scopus
  12. J. V. Busik, M. Tikhonenko, A. Bhatwadekar et al., “Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock,” Journal of Experimental Medicine, vol. 206, no. 13, pp. 2897–2906, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Tuo, X. Guo, X. Zhang, Z. Wang, J. Zhou, L. Xia et al., “The biological effects and mechanisms of calcitonin gene-related peptide on human endothelial cell,” Journal of Receptors and Signal Transduction Research, vol. 33, no. 2, pp. 114–123, 2013. View at Google Scholar
  14. S. Amadesi, C. Reni, R. Katare et al., “Role for substance P-based nociceptive signaling in progenitor cell activation and angiogenesis during ischemia in mice and in human subjects,” Circulation, vol. 125, no. 14, pp. 1774–1786, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. A. J. M. Boulton, “Management of diabetic peripheral neuropathy,” Clinical Diabetes, vol. 23, no. 1, pp. 9–15, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. E. L. Feldman, M. J. Stevens, P. K. Thomas, M. B. Brown, N. Canal, and D. A. Greene, “A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy,” Diabetes Care, vol. 17, no. 11, pp. 1281–1289, 1994. View at Google Scholar · View at Scopus
  17. D. G. Armstrong, L. A. Lavery, and L. B. Harkless, “Validation of a diabetic wound classification system: the contribution of depth, infection, and ischemia to risk of amputation,” Diabetes Care, vol. 21, no. 5, pp. 855–859, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. M. E. Molitch, R. A. DeFronzo, M. J. Franz et al., “Diabetic nephropathy,” Diabetes Care, vol. 26, no. 1, pp. S94–S98, 2003. View at Google Scholar · View at Scopus
  19. Early Treatment Diabetic Retinopathy Study Research Group, “Grading diabetic retinopathy from stereoscopic color fundus photographs—an extension of the modified Airlie House classification ETDRS report number 10,” Ophthalmology, vol. 98, no. 5S, pp. 786–806, 1991. View at Google Scholar
  20. N. Satoh, A. Shimatsu, Y. Kato et al., “Evaluation of the cardio-ankle vascular index, a new indicator of arterial stiffness independent of blood pressure, in obesity and metabolic syndrome,” Hypertension Research, vol. 31, no. 10, pp. 1921–1930, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Weykamp, W. G. John, and A. Mosca, “A review of the challenge in measuring hemoglobin A1c,” Journal of Diabetes Science and Technology, vol. 3, no. 3, pp. 439–445, 2009. View at Google Scholar · View at Scopus
  22. A. Stein and G. L. Myers, Tietz Textbook of Clinical Chemistry, Saunders, New York, NY, USA, 2nd edition, 1994.
  23. H. J. Lambers Heerspink, R. T. Gansevoort, B. M. Brenner et al., “Comparison of different measures of urinary protein excretion for prediction of renal events,” Journal of the American Society of Nephrology, vol. 21, no. 8, pp. 1355–1360, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. L. A. Calò, P. A. Davis, E. Pagnin, L. Dal Maso, P. Caielli, and G. P. Rossi, “Calcitonin gene-related peptide, heme oxygenase-1, endothelial progenitor cells and nitric oxide-dependent vasodilation relationships in a human model of angiotensin II type-1 receptor antagonism,” Journal of Hypertension, vol. 30, no. 7, pp. 1406–1413, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. G. P. Fadini, I. Baesso, M. Albiero, S. Sartore, C. Agostini, and A. Avogaro, “Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau,” Atherosclerosis, vol. 197, no. 2, pp. 496–503, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. G. P. Fadini, D. Losordo, and S. Dimmeler, “Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use,” Circulation Research, vol. 110, no. 4, pp. 624–637, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Asahara, T. Murohara, A. Sullivan et al., “Isolation of putative progenitor endothelial cells for angiogenesis,” Science, vol. 275, no. 5302, pp. 964–967, 1997. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Lin, B. Zhou, and Z. C. Han, “Therapeutic neovascularization by transplantation of mobilized peripheral blood mononuclear cells for limb ischemia. A comparison between CD34+ and CD34 mononuclear cells,” Thrombosis and Haemostasis, vol. 95, no. 2, pp. 301–311, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Moazzami, R. Majdzadeh, and S. Nedjat, “Local intramuscular transplantation of autologous mononuclear cells for critical lower limb ischaemia,” Cochrane Database of Systematic Reviews, vol. 12, Article ID CD008347, 2011. View at Google Scholar · View at Scopus
  30. A. Schiavetta, C. Maione, C. Botti, G. Marino, S. Lillo, A. Garrone et al., “A phase II trial of autologous transplantation of bone marrow stem cells for critical limb ischemia: results of the Naples and Pietra Ligure Evaluation of Stem cells Study,” Stem Cells Translational Medicine, vol. 1, pp. 572–578, 2012. View at Google Scholar
  31. K. Shirai, N. Hiruta, M. Song et al., “Cardio-ankle vascular index (CAVI) as a novel indicator of arterial stiffness: theory, evidence and perspectives,” Journal of Atherosclerosis and Thrombosis, vol. 18, no. 11, pp. 924–938, 2011. View at Google Scholar · View at Scopus
  32. A. I. Vinik, T. Erbas, T. S. Park et al., “Dermal neurovascular dysfunction in type 2 diabetes,” Diabetes Care, vol. 24, no. 8, pp. 1468–1475, 2001. View at Google Scholar · View at Scopus
  33. B. Bakondi, I. S. Shimada, A. Perry et al., “CD133 identifies a human bone marrow stem/progenitor cell sub-population with a repertoire of secreted factors that protect against stroke,” Molecular Therapy, vol. 17, no. 11, pp. 1938–1947, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Peichev, A. J. Naiyer, D. Pereira et al., “Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors,” Blood, vol. 95, no. 3, pp. 952–958, 2000. View at Google Scholar · View at Scopus
  35. U. M. Gehling, S. Ergün, U. Schumacher et al., “In vitro differentiation of endothelial cells from AC133-positive progenitor cells,” Blood, vol. 95, no. 10, pp. 3106–3112, 2000. View at Google Scholar · View at Scopus
  36. S.-W. Kim, H. Kim, and Y.-S. Yoon, “Advances in bone marrow-derived cell therapy: CD31-expressing cells as next generation cardiovascular cell therapy,” Regenerative Medicine, vol. 6, no. 3, pp. 335–349, 2011. View at Publisher · View at Google Scholar · View at Scopus